Merck & Co. Inc. Share Price Today: Live Updates & Key Insights

Merck & Co. Inc. share price today is $114.61, up -0.02%. The stock opened at $114.245 against the previous close of $114.2, with an intraday high of $115.17 and low of $112.72.

Merck & Co. Inc. Share Price Chart

Merck & Co. Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Merck & Co. Inc. Share Price Performance

$114.61 -0.0002(-0.02%) MRK at 23 Mar 2026 02:20 PM Drug Manufacturers - General
Lowest Today 112.72
Highest Today 115.17
Today’s Open 114.245
Prev. Close 114.2
52 Week High 124.22
52 Week Low 70.74
Day’s Range: Low 112.72 High 115.17
52-Week Range: Low 70.74 High 124.22
1 day return -
1 Week return -1.06
1 month return -7.76
3 month return +9.03
6 month return +42.04
1 year return +23.74
3 year return +9.35
5 year return +54.53
10 year return -

Merck & Co. Inc. Institutional Holdings

Vanguard Group Inc 10.29

BlackRock Inc 8.69

State Street Corp 4.78

Wellington Management Company LLP 3.50

Vanguard Total Stock Mkt Idx Inv 3.16

JPMorgan Chase & Co 2.85

Vanguard 500 Index Investor 2.56

Geode Capital Management, LLC 2.43

Charles Schwab Investment Management Inc 1.96

Morgan Stanley - Brokerage Accounts 1.80

FMR Inc 1.65

NORGES BANK 1.54

iShares Core S&P 500 ETF 1.28

Fidelity 500 Index 1.28

Schwab US Dividend Equity ETF™ 1.19

State Street® SPDR® S&P 500® ETF 1.18

Northern Trust Corp 1.13

Bank of America Corp 1.07

Fisher Asset Management, LLC 1.01

Vanguard Value Index Inv 0.92

Bank of New York Mellon Corp 0.88

Amvescap Plc. 0.80

Legal & General Group PLC 0.80

UBS Asset Mgmt Americas Inc 0.80

State Street®HlthCrSelSectSPDR®ETF 0.74

Vanguard Health Care Inv 0.73

UBS Group AG 0.68

Deutsche Bank AG 0.68

Franklin Resources Inc 0.68

Vanguard Equity-Income Inv 0.65

Vanguard Institutional Index I 0.57

Vanguard Dividend Appreciation ETF 0.55

State St S&P 500® Indx SL Cl III 0.54

Vanguard Wellington Inv 0.46

Vanguard Institutional 500 Index Trust 0.45

Vanguard High Dividend Yield ETF 0.41

Blackrock Eq Idx Fund CF 0.36

Russell 1000 Index Fund 0.33

Blackrock Russ 1000 Eq Idx Composite 0.32

Vanguard Health Care ETF 0.31

Merck & Co. Inc. Market Status

Strong Buy: 12

Buy: 3

Hold: 11

Sell: 0

Strong Sell: 0

Merck & Co. Inc. Fundamentals

Market Cap 282297.70 M

PB Ratio 5.3663

PE Ratio 15.7056

Enterprise Value 317071.72 M

Total Assets 136866.00 M

Volume 36355421

Merck & Co. Inc. Company Financials

Annual Revenue FY25:65011000000 65011.0M, FY24:64168000000 64168.0M, FY23:59315000000 59315.0M, FY22:59283000000 59283.0M, FY21:48704000000 48704.0M

Annual Profit FY25:52984000000 52984.0M, FY24:51879000000 51879.0M, FY23:null 0.0M, FY22:41872000000 41872.0M, FY21:35078000000 35078.0M

Annual Net worth FY25:18254000000 18254.0M, FY24:17117000000 17117.0M, FY23:4608000000 4608.0M, FY22:14519000000 14519.0M, FY21:13049000000 13049.0M

Quarterly Revenue Q4/2025:16400000000 16400.0M, Q3/2025:17276000000 17276.0M, Q2/2025:15806000000 15806.0M, Q1/2025:15529000000 15529.0M, Q4/2024:15624000000 15624.0M

Quarterly Profit Q4/2025:15204000000 15204.0M, Q3/2025:13421000000 13421.0M, Q2/2025:12249000000 12249.0M, Q1/2025:12110000000 12110.0M, Q4/2024:14700000000 14700.0M

Quarterly Net worth Q4/2025:2963000000 2963.0M, Q3/2025:5785000000 5785.0M, Q2/2025:4427000000 4427.0M, Q1/2025:5079000000 5079.0M, Q4/2024:3743000000 3743.0M

About Merck & Co. Inc. & investment objective

Company Information Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Organisation Drug Manufacturers - General

Employees 73000

Industry Drug Manufacturers - General

CEO Mr. Robert M. Davis J.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Merck & Co. Inc. FAQs

What is the share price of Merck & Co. Inc. today?

The current share price of Merck & Co. Inc. is $114.61.

Can I buy Merck & Co. Inc. shares in India?

Yes, Indian investors can buy Merck & Co. Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Merck & Co. Inc. shares in India?

You can easily invest in Merck & Co. Inc. shares from India by:

Can I buy fractional shares of Merck & Co. Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Merck & Co. Inc.?

Merck & Co. Inc. has a market cap of $282297.70 M.

In which sector does Merck & Co. Inc. belong?

Merck & Co. Inc. operates in the Drug Manufacturers - General sector.

What documents are required to invest in Merck & Co. Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Merck & Co. Inc.?

The PE ratio of Merck & Co. Inc. is 15.71 and the PB ratio is 5.37.